ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OF PEDIATRIC PATIENTS WITH CONGENITAL… Application EP-4345109-A1 European Patent Office 03 Apr 2024
PROADM AS MARKER INDICATING AN ADVERSE EVENT Application EP-4220175-A1 European Patent Office 02 Aug 2023
ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OR PREVENTION OF SYMPTOMS OF ILLNESS Application EP-4159230-A1 European Patent Office 05 Apr 2023